Genpact (NYSE:G) Upgraded at Wall Street Zen

Genpact (NYSE:G - Get Free Report) was upgraded by Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report released on Friday.

Other equities research analysts have also issued research reports about the company. Robert W. Baird lowered their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Mizuho boosted their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC lowered their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Four analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Genpact presently has an average rating of "Moderate Buy" and a consensus price target of $50.71.

Genpact Price Performance

G stock traded up $0.99 during mid-day trading on Friday, hitting $43.09. 1,606,953 shares of the stock were exchanged, compared to its average volume of 1,376,127. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The business has a fifty day moving average price of $45.98 and a 200 day moving average price of $47.21. Genpact has a 12 month low of $30.38 and a 12 month high of $56.76. The stock has a market capitalization of $7.54 billion, a price-to-earnings ratio of 15.17, a PEG ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the previous year, the company posted $0.73 EPS. Genpact's revenue for the quarter was up 7.4% on a year-over-year basis. On average, sell-side analysts anticipate that Genpact will post 3.21 EPS for the current year.

Insider Buying and Selling at Genpact

In other news, Director Nicholas C. Gangestad bought 2,000 shares of Genpact stock in a transaction on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the acquisition, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Strs Ohio bought a new position in Genpact during the 1st quarter valued at approximately $1,871,000. Acadian Asset Management LLC purchased a new stake in Genpact during the 1st quarter valued at $1,191,000. Focus Partners Wealth boosted its stake in Genpact by 10.3% during the 1st quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider's stock valued at $263,000 after purchasing an additional 488 shares during the last quarter. Bayforest Capital Ltd boosted its stake in Genpact by 482.6% during the 1st quarter. Bayforest Capital Ltd now owns 4,911 shares of the business services provider's stock valued at $247,000 after purchasing an additional 4,068 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Genpact by 12.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider's stock valued at $25,776,000 after purchasing an additional 56,557 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.